Last reviewed · How we verify
Bone marrow aspirate concentrate injection
At a glance
| Generic name | Bone marrow aspirate concentrate injection |
|---|---|
| Also known as | BMAC |
| Sponsor | Istituto Ortopedico Rizzoli |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis (PHASE3)
- Orthobiological Therapies in Musculoskeletal Disorders (EARLY_PHASE1)
- Bone Marrow Versus Adipose Tissue as a Cell Source for Infiltrative Treatment of Knee Osteoarthritis (NA)
- Biologic Injection For Adults With Lumbar Disc Herniation (NA)
- Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction (PHASE4)
- Stem Cells vs. Steroids for Discogenic Back Pain (NA)
- Evaluation of the Single Injection of BMAC vs HA in the Treatment of the Ankle Osteoarthritis (NA)
- Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: